Peculiarities of dyspepsia syndrome in patients with chronic Helicobacter pylori-associated gastritis in the post-eradication period

1. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–79.

PMID: 16678560. https://doi.org/10.1053/j.gastro.2005.11.059

2. Пиманов С.И., Макаренко Е.В. Обновленные рекомендации Маастрихт VI/Флорентийского консенсуса по лечению инфекции Helicobacter pylori. Consilium Medicum. 2022;24(12):851–859. (Pimanov SI, Makarenko EV. Updated the Maastricht VI/Florence Consensus recommendations for the treatment of Helicobacter pylori infection: A review. Consilium Medicum. 2022;24(12):851–859 (In Russ.)).

EDN: YUKZDC. https://doi.org/10.26442/20751753.2022.12.202045

3. Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C et al.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut. 2022:gutjnl-2022-327745. Online ahead of print.

PMID: 35944925. https://doi.org/10.1136/gutjnl-2022-327745

4. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: A global perspective. World J Gastroenterol. 2006;12(17):2661–66.

PMID: 16718749. PMCID: PMC4130971. https://doi.org/10.3748/wjg.v12.i17.2661

5. Xue F, Xue J, Zhao B, Zhu S. The associations of tobacco, alcohol, and coffee consumption with upper and lower gastrointestinal disease risk: A Mendelian randomization study. Gut Liver. 2025;19(5):715–24.

PMID: 40211908. PMCID: PMC12436049. https://doi.org/10.5009/gnl240440

6. Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553–64.

PMID: 37086739. https://doi.org/10.1016/S2468-1253(23)00070-5

7. Андреев Д.Н., Хурматуллина А.Р., Бордин Д.С., Маев И.В. Тенденции распространенности инфекции Helicobacter pylori среди взрослых в Москве: систематический обзор и мета-анализ. Терапевтический архив. 2025;97(5):463–470. (Andreev DN, Khurmatullina AR, Bordin DS, Mayev IV. Trends in the prevalence of Helicobacter pylori infection among adults in Moscow: A systematic review and meta-analysis. Terapevticheskiy arkhiv = Therapeutic Archive. 2025;97(5):463–470 (In Russ.)).

EDN: GYGRXU. https://doi.org/10.26442/00403660.2025.05.203250

8. Zullo A, Hassan C, De Francesco V, Repici A, Manta R, Tomao S et al. Helicobacter pylori and functional dyspepsia: An unsolved issue? World J Gastroenterol. 2014;20(27):8957–63.

PMID: 25083068. PMCID: PMC4112897. https://doi.org/10.3748/wjg.v20.i27.8957

9. Tack J, Palsson OS, Bangdiwala SI, Schol J, Carbone F, Van Den Houte K et al. Functional dyspepsia and its subgroups: Prevalence and impact in the Rome IV Global Epidemiology Study. Aliment Pharmacol Ther. 2025;62(3):330–39.

PMID: 40434285. PMCID: PMC12239946. https://doi.org/10.1111/apt.70189

10. Malfertheiner P, MOssner J, Fischbach W, Layer P, Leodolter A, Stolte M, Demleitner K, Fuchs W. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther. 2003 Sep 15;18(6):615-25. doi: 10.1046/j.1365-2036.2003.01695.x. PMID: 12969088.

11. Жесткова Т.В. Оценка динамики симптомов диспепсии после эрадикационной терапии у пациентов с Helicobacter pylori-ассоциированным гастритом. Экспериментальная и клиническая гастроэнтерология. 2022;(10):14–18. (Zhestkova TV. Evaluation of the dynamics of symptoms of dyspepsia after eradication therapy in patients with Helicobacter pylori-associated gastritis. Eksperimental'naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2022;(10):14–18 (In Russ.)).

EDN: XHAEYY. https://doi.org/10.31146/1682-8658-ecg-206-10-14-18

12. Talley N, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months’ follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ. 1999;318(7187):833–37.

PMID: 10092259. PMCID: PMC27795. https://doi.org/10.1136/bmj.318.7187.833

13. Hong S, Sung I, Kim J, Lee S, Choi S, Yang C et al.; H. pylori and Dyspepsia Study Group of Korean College of Helicobacter and Upper Gastrointestinal Research. Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori-infected patients with functional dyspepsia. Gut Liver. 2011;5(4):468–71.

PMID: 22195245. PMCID: PMC3240790. https://doi.org/10.5009/gnl.2011.5.4.468

14. Rahim M, Durr-E-Sabih, Mateen A, Najam-Uddin, Yousaf M. Studies of gastric emptying time in patients with non-ulcer dyspepsia. Nucl Med Commun. 2007;28(11):852–58.

PMID: 17901768. https://doi.org/10.1097/MNM.0b013e3282f0d167

15. Kourikou A, Karamanolis GP, Dimitriadis GD, Triantafyllou K. Gene polymorphisms associated with functional dyspepsia. World J Gastroenterol. 2015;21(25):7672–82.

PMID: 26167069. PMCID: PMC4491956. https://doi.org/10.3748/wjg.v21.i25.7672

16. Maes B, Ghoos Y, Hiele M, Rutgeerts P. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci. 1997;42(6):1158–62.

PMID: 9201077. https://doi.org/10.1023/a:1018881419010

17. Quartero A, de Wit N, Lodder A, Numans M, Smout A, Hoes A. Disturbed solid-phase gastric emptying in functional dyspepsia: A meta-analysis. Dig Dis Sci. 1998;43(9):2028–33.

PMID: 9753269. https://doi.org/10.1023/a:1018803129779

18. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110(4):1036–42.

PMID: 8612991. https://doi.org/10.1053/gast.1996.v110.pm8612991

19. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98(4):783–88.

PMID: 12738456. https://doi.org/10.1111/j.1572-0241.2003.07389.x

20. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115(6):1346–52.

PMID: 9834261. https://doi.org/10.1016/s0016-5085(98)70012-5

21. Kim Y, Delgado-Aros S, Camilleri M, Samsom M, Murray A, O’Connor M et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol. 2001;96(11):3099–105.

PMID: 11721755. https://doi.org/10.1111/j.1572-0241.2001.05264.x

22. Vermeulen W, De Man J, Pelckmans P, De Winter B. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol. 2014;20(4):1005–20.

PMID: 24574773. PMCID: PMC3921524. https://doi.org/10.3748/wjg.v20.i4.1005

23. Chang J, Talley N. Current and emerging therapies in irritable bowel syndrome: From pathophysiology to treatment. Trends Pharmacol Sci. 2010;31(7):326–34.

PMID: 20554042. https://doi.org/10.1016/j.tips.2010.04.008

24. Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita AV et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63(2):262–71.

PMID: 23474421. https://doi.org/10.1136/gutjnl-2012-303857

25. Broeders BWLCM, Carbone F, Balsiger LM, Schol J, Raymenants K, Huang I et al. Review article: Functional dyspepsia – a gastric disorder, a duodenal disorder or a combination of both? Aliment Pharmacol Ther. 2023;57(8):851–60.

PMID: 36859629. https://doi.org/10.1111/apt.17414

26. Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, Verschueren S, Houben E et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut. 2014;63(8):1293–99.

PMID: 24153250. https://doi.org/10.1136/gutjnl-2013-305690

27. Oshima T, Miwa H. Functional dyspepsia – a revolution in management. Am J Gastroenterol. 2018;113(10):1420–22.

PMID: 30181534. https://doi.org/10.1038/s41395-018-0264-8

28. Kunzelmann K, Mall M. Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev. 2002;82(1):245–89.

PMID: 11773614. https://doi.org/10.1152/physrev.00026.2001

29. Van Itallie C, Anderson J. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68:403–29.

PMID: 16460278. https://doi.org/10.1146/annurev.physiol.68.040104.131404

30. Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, Fromm M. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci. 2002;115(Pt 24):4969–76.

PMID: 12432083. https://doi.org/10.1242/jcs.00165

31. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S et al. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci. 2010;123(Pt 11):1913–21.

PMID: 20460438. https://doi.org/10.1242/jcs.060665

32. Turksen K, Troy T. Barriers built on claudins. J Cell Sci. 2004;117(Pt 12):2435–47.

PMID: 15159449. https://doi.org/10.1242/jcs.01235

33. Gumbiner BM. Breaking through the tight junction barrier. J Cell Biol. 1993;123(6 Pt 2):1631–33.

PMID: 8276885. PMCID: PMC2290864. https://doi.org/10.1083/jcb.123.6.1631

34. Hartsock A, Nelson W. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778(3):660–69.

PMID: 17854762. PMCID: PMC2682436. https://doi.org/10.1016/j.bbamem.2007.07.012

35. Schneeberger E, Lynch R. Structure, function, and regulation of cellular tight junctions. Am J Physiol. 1992;262(6 Pt 1):L647–61.

PMID: 1616050. https://doi.org/10.1152/ajplung

36. Полуэктова Е.А., Ляшенко О.С., Королев А.В., Шифрин О.С., Ивашкин В.Т. Механизмы, обеспечивающие взаимодействие бактериальных клеток с организмом хозяина, и их нарушение у пациентов с воспалительными заболеваниями кишечника. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(6):42–53. (Poluektova YeA, Lyashenko OS, Korolev AV, Shifrin OS, Ivashkin VT. Mechanisms of bacterial-to-host interaction and their disorders at inflammatory bowel diseases. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(6):42–53 (In Russ.)). EDN: TEYMCN.

37. Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita AV et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63(2):262–71.

PMID: 23474421. https://doi.org/10.1136/gutjnl-2012-303857

38. Qiu J, Liu Z, Zhao P, Wang XJ, Li YC, Sui H et al. Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model. World J Gastroenterol. 2017;23(5):810–16.

PMID: 28223725. PMCID: PMC5296197. https://doi.org/10.3748/wjg.v23.i5.810

39. Кучерявый Ю.А., Андреев Д.Н., Маев И.В. Распространенность синдрома избыточного бактериального роста в тонкой кишке у пациентов с функциональной диспепсией: метаанализ. Терапевтический архив. 2020;92(12):53–58. (Kucheryavy YuA, Andreev DN, Mayev IV. Prevalence of bacterial overgrowth syndrome in the small intestine in patients with functional dyspepsia: A meta-analysis. Terapevticheskiy arkhiv = Therapeutic Archive. 2020;92(12):53–58 (In Russ.)).

EDN: FELQJR. https://doi.org/10.26442/00403660.2020.12.200433

40. Igarashi M, Nakae H, Matsuoka T, Takahashi S, Hisada T, Tomita J, Koga Y. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ. 2017;4(1):e000144.

PMID: 28761692. PMCID: PMC5508964. https://doi.org/10.1136/bmjgast-2017-000144

41. Nakae H, Tsuda A, Matsuoka T, Mine T, Koga Y. Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt. 2016;3(1):e000109.

PMID: 27752337. PMCID: PMC5051319. https://doi.org/10.1136/bmjgast-2016-000109

42. Cervantes J, Michael M, Hong BY, Springer A, Guo H, Mendoza B et al. Investigation of oral, gastric, and duodenal microbiota in patients with upper gastrointestinal symptoms. J Investig Med. 2020:jim-2020-001642. Online ahead of print.

PMID: 33335025. https://doi.org/10.1136/jim-2020-001642

43. Fukui A, Takagi T, Naito Y, Inoue R, Kashiwagi S, Mizushima K et al. Higher levels of Streptococcus in upper gastrointestinal mucosa associated with symptoms in patients with functional dyspepsia. Digestion. 2020;101(1):38–45.

PMID: 31752012. https://doi.org/10.1159/000504090